Over-the-counter medicines

被引：9

作者：

Aronson, JK ^{[1
]}

机构：

[1] Radcliffe Infirm, Univ Dept Clin Pharmacol, Oxford OX2 6HE, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 58卷 / 03期

关键词：

D O I：

10.1111/j..2004.02191.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：231 / 234

页数：4

共 13 条

[1]

[Anonymous], 2004, LANCET, V363, P1659

[2]

[Anonymous], CURR PROBL PHARMACOV

[3] Features of this month's Journal [J].

Aronson, JK .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (03) :223-224

[4]

BHATTACHARYA S, 2004, NEW SCI, V16, P35

[5]

*COMM SAF MED MED, 1999, CURR PROBL PHARMACOV, V25, P2

[6] The road to health care - Balancing benefits and harms of interventions is essential [J].

Cuervo, LG ;

Aronson, JK .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456) :1-2

[7] Which drugs should be available over the counter? The criteria are clear and include safety, timeliness, and opportunity cost [J].

Fenichel, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7459) :182-183

[8] Making decisions about benefits and harms of medicines [J].

Greenhalgh, T ;

Kostopoulou, O ;

Harries, C .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456) :47-50B

[9]

HUNT JA, 2001, PHARM J, V266, P191

[10] Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis [J].

Law, MR ;

Wald, NJ ;

Rudnicka, AR .

BRITISH MEDICAL JOURNAL, 2003, 326 (7404) :1423-1427

← 1 2 →